Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations
Deka Biosciences (“Deka”), a biotech company focused on the development of novel cytokine therapies to […]
ArisGlobal Accelerates Growth, Announces Executive Evolution
ArisGlobal, the leading provider of life sciences software that automates core drug development functions with […]
Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials
Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a […]
Freenome Launches Its First Study for the Detection of Multiple Cancers That Pairs Multiomics With Real-World Data
Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the […]
Verseon Gains European Patent Protection for Potential Sight and Life-Saving Treatments
Verseon is pleased to announce that the European Patent Office has granted intellectual property protection […]
Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology
Biosense Webster, Inc., part of Johnson & Johnson MedTech[†], today announced the release of the […]
Tri-anim Health Services Announces Exclusive Relationship to Distribute Brainscope's Breakthrough Technology for Mild Head Injury Including Concussion, Into Emergency Departments
Tri-anim Health Services, a specialty distributor of respiratory, anesthesia and critical care products and therapies, […]
Elephas Announces $41.5 Million in Series B Funding
Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $41.5 million in Series […]
Thailand Heightens Its Healthcare Hub Ambition With Integrative Medicine
Living with the COVID-19 pandemic, people start to recognize the equal importance of modern medicine and […]
Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU
Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more